Cubist Pharmaceuticals Completes $90 Million Financing; Underwriters Exercise Over-Allotment Option in Full.Business Editors/Health/Medical Writers BIOWIRE2K LEXINGTON, Mass.--(BUSINESS WIRE)--Oct. 21, 2003 Cubist Pharmaceuticals, Inc. (Nasdaq: CBST CBST Center for Biophotonics Science and Technology CBST Congregation Beth Simcha Torah (NYC) CBST Complete Binary Search Tree ) today announced the completion of its public offering of 7,453,400 shares of Cubist common stock at $10.50 per share. The company also announced today that the underwriters of this offering exercised in full their option to purchase an additional 1,118,010 shares of Cubist common stock at $10.50 per share. Gross proceeds of $90 million represent a 20% increase over the original "shelf" registration statement previously filed with the Securities and Exchange Commission. Proceeds to the company from this offering, net of underwriters' commissions and discounts, totaled $84.6 million. The sole bookrunner bookrunner See lead underwriter. for the offering was Morgan Stanley  To comply with Wikipedia's , the introduction of this article needs a complete rewrite. & Co. Incorporated; Pacific Growth Equities, LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control was a co-lead manager; and co-managers of the offering were WR Hambrecht+Co, LLC and Harris Nesbitt Gerard, Inc. This communication shall not constitute an offer to sell or a solicitation solicitation In criminal law, the act of asking, inducing, or directing someone to commit a crime. The person soliciting another becomes an accomplice to the crime. The term also refers to the act of obtaining bribes, as well as to the crime of a prostitute who offers sexual of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. About Cubist Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development and commercialization of antiinfective antiinfective /an·ti·in·fec·tive/ (-in-fek´tiv) counteracting infection, or an agent that does this. drugs. Cubist is headquartered in Lexington, MA. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion